Related references
Note: Only part of the references are listed.Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue
Paul B. Jacobsen et al.
HEALTH PSYCHOLOGY (2007)
A randomized controlled trial to evaluate the effectiveness of a brief, behaviorally oriented intervention for cancer-related fatigue
Jo Armes et al.
CANCER (2007)
The association between fatigue and inflammatory marker levels in cancer patients: A quantitative review
Christian Schubert et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia
James R. Wright et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Stress sensitivity in metastatic breast cancer: Analysis of hypothalamic-pituitary-adrenal axis function
David Spiegel et al.
PSYCHONEUROENDOCRINOLOGY (2006)
Comparison between fatigue, sleep disturbance, and circadian rhythm in cancer inpatients and healthy volunteers: Evaluation of diagnostic criteria for cancer-related fatigue
Roland Fernandes et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2006)
Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial
E Bruera et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Cancer-related fatigue: A critical appraisal
G. Prue et al.
EUROPEAN JOURNAL OF CANCER (2006)
Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients
JP Monk et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial
PM Wilkinson et al.
BRITISH JOURNAL OF CANCER (2006)
Fatigue in long-term breast carcinoma survivors - A longitudinal investigation
JE Bower et al.
CANCER (2006)
Supportive intervention for fatigue in patients undergoing chemotherapy: A randomized controlled trial
E Ream et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2006)
Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer
JT Hickok et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2005)
Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer
MA Andrykowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial
JH Savonije et al.
EUROPEAN JOURNAL OF CANCER (2005)
Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy
J Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy
TE Witzig et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue
JE Bower et al.
PSYCHOSOMATIC MEDICINE (2005)
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
B Leyland-Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effect of paroxetine hydrochloride (Paxil®) on fatigue and depression in breast cancer patients receiving chemotherapy
JA Roscoe et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Fatigue in cancer patients receiving chemotherapy: an analysis of published studies
A Iop et al.
ANNALS OF ONCOLOGY (2004)
Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer
KA Donovan et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2004)
Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer
IJ Diel et al.
EUROPEAN JOURNAL OF CANCER (2004)
Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program
GR Morrow et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study
D Kotasek et al.
EUROPEAN JOURNAL OF CANCER (2003)
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies:: a randomized, double-blind, placebo-controlled study
M Hedenus et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy -: results of a randomized trial
JP Glossmann et al.
ANNALS OF HEMATOLOGY (2003)
A dose- and schedule-finding study of darbepoetin alpha for the treatment of chronic anaemia of cancer
RE Smith et al.
BRITISH JOURNAL OF CANCER (2003)
Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: Results of a randomized, controlled trial
G Iconomou et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2003)
Impact of epoetin β on quality of life in patients with malignant disease
M Boogaerts et al.
BRITISH JOURNAL OF CANCER (2003)
Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human erythropoietin (rHuEpo): A prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group
A Bamias et al.
ONCOLOGY (2003)
Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales
D Cella et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy
JA Glaspy et al.
BRITISH JOURNAL OF CANCER (2002)
Palliative uses of methylphenidate in patients with cancer: A review
M Rozans et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer
RE Smith et al.
BRITISH JOURNAL OF CANCER (2001)
A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease
W Breitbart et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Share Paper
